FREE SHIPPING ON ORDERS OVER $150

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

$21.07

Quantity
- +
Description

By activating transforming growth factor (TGF)-1, the BPC-157 peptide leads to an increased number of capillaries without an increase in their diameter, advanced formation of skin reticulin and collagen fibers, and an increased number of preserved hair follicles

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

J Am Soc Nephrol 1988;9:17981804

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

GHK-Cu addresses structural aging (skin, hair, connective tissue), while NAD+ addresses functional aging (energy metabolism, DNA repair, cognitive sharpness)

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

Both vitamins are essential for DNA synthesis.Vitamin B6 is also beneficial as it aids in the metabolism of B12

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

slump 1h23m57s

ghk-cu clinical trials evidence Epigenetic mechanisms activated by increase skin collagen density in trial GHK-Cu Benefits: Evidence & Biomarker

You may also like

recommand products